Literature DB >> 12581259

The pathogenesis and management of painful diabetic neuropathy: a review.

M C Spruce1, J Potter, D V Coppini.   

Abstract

Painful diabetic neuropathy has always been a challenging complication of diabetes mellitus. Emerging theories suggest that early dysaesthesia associated with painful neuropathy may act as a marker for the development of the 'at risk' foot, allowing preventative clinical strategies to be undertaken. The mechanisms of neuropathic pain are complex. The authors' intentions are to help members of the diabetes care team better understand and appreciate the diverse symptoms reported by patients. The various treatments available for painful neuropathy are discussed in detail. Robust comparative studies on such treatments are, however, unavailable and the authors have designed a logical approach to management based on best current evidence and their own clinical experience.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12581259     DOI: 10.1046/j.1464-5491.2003.00852.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  18 in total

1.  Contributions of purinergic P2X3 receptors within the midbrain periaqueductal gray to diabetes-induced neuropathic pain.

Authors:  Jianfei Guo; Xudong Fu; Xia Cui; Minhua Fan
Journal:  J Physiol Sci       Date:  2014-11-01       Impact factor: 2.781

2.  Inhibition of prohormone convertases PC1/3 and PC2 by 2,5-dideoxystreptamine derivatives.

Authors:  Mirella Vivoli; Thomas R Caulfield; Karina Martínez-Mayorga; Alan T Johnson; Guan-Sheng Jiao; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2011-12-14       Impact factor: 4.436

3.  The diabetic neuropathies: types, diagnosis and management.

Authors:  J Gareth Llewelyn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

Review 4.  Pregabalin: in the treatment of postherpetic neuralgia.

Authors:  James E Frampton; Rachel H Foster
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?

Authors:  Kevin L Farmer; Chengyuan Li; Rick T Dobrowsky
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

Review 6.  Inhibitors of proprotein convertases.

Authors:  Ajoy Basak
Journal:  J Mol Med (Berl)       Date:  2005-10-08       Impact factor: 4.599

Review 7.  Treatment of painful polyneuropathies.

Authors:  Bruce Nicholson
Journal:  Curr Pain Headache Rep       Date:  2005-06

Review 8.  Pregabalin: in the treatment of painful diabetic peripheral neuropathy.

Authors:  James E Frampton; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  [Treatment options in painful diabetic polyneuropathy].

Authors:  Juan J Archelos
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

10.  Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat.

Authors:  Shuangsong Hong; Thomas J Morrow; Pamela E Paulson; Lori L Isom; John W Wiley
Journal:  J Biol Chem       Date:  2004-05-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.